Heilind Electronics Announces Distribution Partnership with GCT (Global Connector Technology)
21. Oktober 2024 13:00 ET
|
Heilind Electronics
WILMINGTON, Mass., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Heilind Electronics, a global leader in electronics distribution, announces a new global distribution partnership with GCT (Global Connector...
Sandoz US launches generic paclitaxel in single-dose vial, further expanding US oncology portfolio
11. Oktober 2024 01:00 ET
|
Sandoz Group
MEDIA RELEASE First FDA-approved abbreviated new drug application (ANDA) to reference medicineSingle-dose 100 mg vial for intravenous use, approved for metastatic breast cancerLaunch expected to be...
Heilind Electronics Introduces Brady M410 and M510 Series Printers
09. September 2024 11:48 ET
|
Heilind Electronics
WILMINGTON, Mass., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Heilind Electronics, a global leader in electronics distribution, announces Brady’s new line of M410 and M510 label printers. The M410 series...
Heilind Electronics Features Molex UltraWize Wire-to-Board High-Current Connectors & Cable Assemblies
12. August 2024 09:45 ET
|
Heilind Electronics
WILMINGTON, Mass., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Heilind Electronics, a leading global distributor of electronic components and authorized distributor for Molex, is now stocking Molex UltraWize...
Heilind Electronics Featuring Hirose DF60FS Series Wire-to-Board Connectors
27. Juni 2024 10:30 ET
|
Heilind Electronics
WILMINGTON, Mass., June 27, 2024 (GLOBE NEWSWIRE) -- Heilind Electronics, a leading global distributor of interconnect, electromechanical, and sensor products, features the Hirose DF60FS Series...
Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab biosimilars
30. April 2024 01:00 ET
|
Sandoz Group
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab biosimilars Agreement...
Sandoz confirms European Commission approval of Pyzchiva® (ustekinumab), further strengthening immunology offering
22. April 2024 01:00 ET
|
Sandoz Group
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Pyzchiva® approved as one of first ustekinumab biosimilars in EuropeEC approval based on robust development program...
THE BROOKLYN ROASTING COMPANY INTRODUCES TWO SUPER-PREMIUM COFFEE BLENDS TO THE KEURIG® K-CUP® POD SYSTEM
10. April 2024 10:00 ET
|
The Brooklyn Roasting Company
Brooklyn, NY, April 10, 2024 (GLOBE NEWSWIRE) -- The Brooklyn Roasting Company, New York's best-loved local roasting company, today announced a new partnership with Keurig Dr Pepper (KDP) with the...
Nerdio Unveils Major Upgrades in Nerdio Manager for Enterprise and Nerdio Manager for MSP, Enhancing Both Platforms
02. April 2024 09:00 ET
|
Nerdio
CHICAGO, April 02, 2024 (GLOBE NEWSWIRE) -- Nerdio, a premier solution for organizations of all sizes looking to manage and cost-optimize native Microsoft cloud technologies, today announced...
Sandoz receives FDA approval for first and only denosumab biosimilars
05. März 2024 13:24 ET
|
Sandoz Group
MEDIA RELEASE Wyost® (denosumab-bddz) and Jubbonti® (denosumab-bddz) interchangeable with and approved by FDA for all indications of reference medicines Xgeva ®* (denosumab) and Prolia®*...